Acta Diabetologica

Papers
(The H4-Index of Acta Diabetologica is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
The prevalence of mild cognitive impairment in type 2 diabetes mellitus patients: a systematic review and meta-analysis112
The relationship between gut microbiota, short-chain fatty acids and type 2 diabetes mellitus: the possible role of dietary fibre64
The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-1948
Short-term impact of COVID-19 lockdown on metabolic control of patients with well-controlled type 2 diabetes: a single-centre observational study44
Improved technology satisfaction and sleep quality with Medtronic MiniMed® Advanced Hybrid Closed-Loop delivery compared to predictive low glucose suspend in people with Type 1 Diabetes in a randomize38
Novel biomarkers of diabetic kidney disease: current status and potential clinical application38
Type 2 diabetes mellitus and sepsis: state of the art, certainties and missing evidence38
Telehealth strategy to mitigate the negative psychological impact of the COVID-19 pandemic on type 2 diabetes: A randomized controlled trial38
Association of remnant cholesterol with chronic kidney disease in middle-aged and elderly Chinese: a population-based study36
Fecal microbiota signatures of insulin resistance, inflammation, and metabolic syndrome in youth with obesity: a pilot study33
Prevalence of periodontitis in people clinically diagnosed with diabetes mellitus: a meta-analysis of epidemiologic studies31
The contribution of the English NHS Diabetic Eye Screening Programme to reductions in diabetes-related blindness, comparisons within Europe, and future challenges31
Impact of diabetes mellitus on in-hospital mortality in adult patients with COVID-19: a systematic review and meta-analysis31
Farnesoid X receptor (FXR) agonist ameliorates systemic insulin resistance, dysregulation of lipid metabolism, and alterations of various organs in a type 2 diabetic kidney animal model30
Sodium-glucose cotransporter 2 inhibition prevents renal fibrosis in cyclosporine nephropathy30
Glycemic control of children and adolescents with type 1 diabetes improved after COVID-19 lockdown in Italy27
Glycemic control, depression, diabetes distress among adolescents with type 1 diabetes: effects of sex, race, insurance, and obesity25
Klotho protects against diabetic kidney disease via AMPK- and ERK-mediated autophagy25
Glucose control in diabetes during home confinement for the first pandemic wave of COVID-19: a meta-analysis of observational studies24
Alterations in Rev-ERBα/BMAL1 ratio and glycated hemoglobin in rotating shift workers: the EuRhythDia study23
Metformin use and risk of COVID-19 among patients with type II diabetes mellitus: an NHIS-COVID-19 database cohort study23
Silencing lncRNA GAS5 alleviates apoptosis and fibrosis in diabetic cardiomyopathy by targeting miR-26a/b-5p22
Liraglutide targets the gut microbiota and the intestinal immune system to regulate insulin secretion22
0.82561087608337